ARCHIVES

Celgene Signs CRADA With NCI For Development Of CDC-501.

This article is from The Cancer Letter archive.

Vol. 26 No. 26 | June 30, 2000

Download PDF Visit The Full Archive

Related Articles

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

Network Should Collect Some Environmental Information: Collins

August 9, 1996

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995

Eight Years Later:In A Change of Heart, LCA Endorses NLST

April 18, 2014

Rauscher Tells Flood Subcommittee How He Would Spend An Extra $50 Million-On Centers, Grants

April 5, 1974

RFAs Available: Silicone And Immune Response; Role Of Metallotionein; Dietary Fat Biomarkers

September 11, 1992